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Chromatin immunoprecipitation (ChIP) is an assay developed in order to define the
dynamic nature of transcription processes. This method has been widely employed
to identify methylated and acetylated DNA sequences in a variety of organs both in
animals and humans. Nevertheless, this technique is significantly less employed to
study transcriptional targets of specific nuclear signaling factors (TFs) and the data
published so far have mainly used cell culture material and have been hardly reproduced
in ex-vivo tissue. As nuclear signaling underlies important adaptive and maladaptive
responses in chronic conditions such as cancer and neurodegeneration, there is a need
for streamlining the upfront workflow of TF-ChIP for subsequent target sequencing.
Based on the typical low concentration of the signaling transcriptional complex and
the complexity/length of the ChIP Seq protocol, the field of cellular signaling has been
confronted with a major roadblock in identifying clinically relevant targets of pathological
and physiological signaling pathways. The present protocol offers a standardized
procedure for detecting signaling targets in any whole tissue or specific dissected
regions. The advantages of the protocol compared to the existing published methods
are: (1) the small amount of starting material; appropriate for tissue subregions; (2)
the optimization of DNA fragmentation from whole tissue; (3) suitability for sparsely
populated tissues (i.e., brain); (4) the specificity of the TF-targeting readout; and (5)
high DNA quality for sequencing or hybridization. The present protocol is highly detailed
and can be reproduced using both fresh and fresh-frozen tissue. This is particularly
relevant in the clinical setting, where specimen integrity is often the limiting step and
where transcriptional target profiling is therapeutically relevant. The method is centered
on Notch signaling but can be applied to a variety of nuclear signaling pathways as long
as specific antibodies are available for pull down. Taken the superior yield/readout of this
procedure, ChIP may finally provide relevant information about dynamic downstream
gene changes in vivo for use in both basic research and clinical applications.
Keywords: ChIP, transcription factor, Notch signaling, brain, low amount DNA, region-specific, gene expression
INTRODUCTION
Control of gene expression is essential for a cell to assemble the gene products it needs to
regulate cellular homeostasis and communication. Virtually, any step of gene expression can
be modulated, from the DNA–RNA transcription step (Genuth and Barna, 2018) to transcripts
triaging through miRNA, transcript splicing, protein translation through initiation complex, and
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post-translational modification of a protein (Mansuy and
Mohanna, 2011). The various checkpoints of gene expression
warrant a finely tuned biological repertoire determining
the cellular identity in a context-dependent manner. Direct
interaction of a protein with DNA is the simplest and the most
direct method by which a protein changes transcription
levels conferring the appropriate fitness in response to
environmental changes (Olfson and Ross, 2017). In the
setting of neurons, transcriptional control is often activity
dependent and induces the expression of genes regulating
synaptic plasticity and neuronal network function (Flavell and
Greenberg, 2008; Engelmann and Haenold, 2016). Under this
light, the transcription factor (TF) assumes high relevance. By
binding to a specific DNA sequence, a TF controls the rate of
transcription of genetic information and it represents the last
wheel in the gear chain of a signaling pathway, determining the
pathways functional outcome. Nonetheless, most TFs do not
work alone. Many large TF families form complex homotypic or
heterotypic interactions through dimerization and others may
recruit intermediary proteins such as cofactors that modulate the
effects of TFs by promoting (activator) or blocking (repressor)
the recruitment of RNA polymerase to specific genes and their
transcription (Vaquerizas et al., 2009).
Furthermore, despite transcriptional processes are highly
conserved, human tissues differ from other mammalian species
by gene expression patterns thereby adding another layer of
complexity (Qian et al., 2005; Huang et al., 2018).
One of the techniques that has best helped understanding
transcriptional factors’ biological relevance is chromatin
immunoprecipitation (ChIP). ChIP is a powerful technique used
to detect, map, and quantify the contacts established between the
protein of interest and genomic DNA in vivo.
As its name suggests, ChIP relies on the use of antibodies
to precipitate or pull-down a DNA-binding protein of interest
bound to its genomic locus. These DNA fragments are, then,
isolated and characterized in order to draw conclusions about a
certain transcriptional process.
Despite a simple working principle, ChIP is notoriously
technically challenging, highly sensitive to operational errors and
artifacts, and often requires a great deal of upfront optimization
before reliable results can be obtained. Moreover, it is expensive
and time-consuming.
Here, we present a protocol optimized for TF in brain tissues
whose extraordinary complexity is thought to rely on refined
transcriptional networks and hierarchies.
In particular, we choose to perform this protocol in the Cornus
Ammonis (CA) field of the hippocampus (comparing it with
cortex) in order to demonstrate the validity of the technique for
a little amount of region-specific starting material and provide
a best practice TF-ChIP method for researchers working with
whole animal and human tissue.
We decided to focus on Notch1 signaling pathway since it
provides a good example for low complexity pathway studies.
Notch signaling is a well-known player in the embryonic
development but increasing evidence points out a critical role in
the mature brain of vertebrates and invertebrates. This pathway
appears to be involved in neural progenitor regulation, neuronal
connectivity, synaptic plasticity, and learning/memory (Alberi
et al., 2013). In addition, Notch was also found aberrantly
regulated in neurodegenerative diseases, including Alzheimer’s
disease and ischemic injury both in rodent models and human
tissue (Brai et al., 2016; Marathe et al., 2017) but the mechanistic
implication of Notch-dependent targets in this setting remains
largely unraveled, limiting its clinical relevance. The signaling is
composed by a downstream transcriptional factor, recombining
binding protein suppressor of hairless (RBPjK) that normally
behaves as a repressor and that needs another protein, Notch
intracellular domain (NICD), to be activated and transcribe
its target genes. Notch1 signaling has a sophisticated program
of gene expression orchestrated by the alternating status of
RBPjK. Notch1 is a transmembrane receptor scattered across
the cell membrane. Ligand proteins bind to the extracellular
domain inducing proteolytic cleavage and release the intracellular
domain (NICD), which enters in the nucleus and binds RBPjK.
This allows transcription and the subsequent cell response
(Siebel and Lendahl, 2017).
The ChIP assay executed in this manuscript is performed
specifically in the hippocampal CA fields and involves NICD
precipitation in order to assess target genes downstream Notch1
canonical activation.
This work aims to explain in detail the critical steps of the
procedure which can be further adapted to any experimental
setting using ex-vivo tissue (tissues with high extracellular
matrix density, secondary factor precipitation, low chromatin
yield, signaling pathways with few target genes, etc.) in a
very short time.
MATERIALS AND EQUIPMENT
Animals
All experiments on mice were performed with permission of the
local animal care committee (Canton of Fribourg, Switzerland
approved the Protocol no. 2016_32_FR) and according to the
present Swiss law and the European Communities Council
Directive of 24 November 1986 (86/609/EEC). C57Bl6 male
mice were used throughout the experiment. Transgenic Notch
Reporter [Tg(C-EGFP) 25 Gaia/Reya; Jax, FL, United States] was
used for fluorescent immunohistochemistry (IHC). All animals
(3 months of age) were housed on 12 h light–dark cycle with
access to food and water ad libitum. Mice were euthanized using
pentobarbital (120 mg/kg). Once no pinch reflex was assessed,
animals were perfused using 0.9% NaCl and either dissected in
ice cold saline solution under a stereoscope (Leica, Germany)
or immersion fixed using paraformaldehyde (Sigma–Aldrich,
United States; P6148).
ChIP Equipment
Glass dish
Razor blades
Pestle
Eppendorf
Pippettor
Rotating wheel
Prism RTM Refrigerated MicroCentrifuge (Labnet,
Switzerland; C2500-R)
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Vortex-Genie 2 (Scientific Industries, Inc., United States;
SI-0236)
Bioruptor Plus (Diagenode, Belgium; B01020001)
1.5 ml Bioruptor R© Plus TPX microtubes (Diagenode,
Belgium; C30010010-300)
Qubit Fluorometric Quantitation (Thermo Fisher,
United States; Q33226)
ThermoMixer R© C (Eppendorf, Germany; #5382000015)
Mupid R©-One Electrophoresis System (Eurogentec,
Germany)
Omega LumTM W Imaging System (Aplegen, United States;
81-12120-00)
Biometra TRIO Thermal Cycler Series (Analytik Jena,
Germany)
Fragment Analyzer (Advanced Analytical AATI,
United States)
Mic qPCR Cycler (Bio Molecular Systems, Australia).
ChIP Reagents
Formaldehyde solution, 36.5–38% (Sigma-Aldrich,
United States; F8775) !caution formaldehyde is toxic by
inhalation, ingestion, or contact with skin.
Phosphate-buffered saline (PBS) (10×) pH 7.4 (Thermo
Fisher Scientific, United States; AM9625)
Glycine (Sigma–Aldrich, United States; G8898)
Protease inhibitor (PI) cocktail (Sigma–Aldrich,
United States; P8340)
Sodium dodecyl sulfate (SDS) (Roth, Germany; CN30.3)
!caution SDS is toxic by inhalation, ingestion, or
contact with skin.
Ethylenediaminetetraacetic acid (EDTA) (Sigma–Aldrich,
United States; E5134)
Tris (Roth, Germany; 5429.3)
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
(HEPES) (Sigma–Aldrich, United States; H3375)
NaCl (Roth, Germany; 9265.2)
Sodium deoxycholate (Sigma–Aldrich, United States;
30970)
Triton X-100 (Sigma–Aldrich, United States; 93426)
Tris–HCl (Roth, Germany; 9090)
LiCl (Sigma–Aldrich, United States; L9650)
Nonidet P-40 substitute (Sigma–Aldrich, United States;
74385)
QubitTM dsDNA HS Assay Kit (Thermo Fisher,
United States; Q32851)
PierceTM Protein A/G Agarose (Thermo Fisher,
United States; 20421)
Antibodies: Rabbit anti-NICD (Cell Signaling,
United States; #4147); Rabbit IgG (Cell Signaling,
United States; #2729); and Rabbit anti-Acetyl-Histone H3
(Lys9) (Cell Signaling, United States; #9649)
RNase A solution (Promega, United States; A7974)
Proteinase K (Roche, Switzerland; 03508838103)
Phenol/chloroform/isoamyl alcohol (Roth, Germany;
A156) !Caution chloroform is toxic if absorbed through the
skin, inhaled or ingested.
Chloroform/isoamyl alcohol (Roth, Germany; X984)
!Caution chloroform is toxic if absorbed through the skin,
inhaled or ingested.
Sodium acetate (Merck, Germany; 1.06268.0250)
Glycogen (Roche;10901393001)
Isopropanol (Fisher Chemical, United States; P/7500/15)
Ethanol absolute (Fisher Chemical, United States;
E/0650DF/15)
Agarose standard (Roth, Germany; 3810)
SYBRTM Safe DNA Gel Stain (Thermo Fisher,
United States; S33102)
GoTaq R© Hot Start Green Master Mix (Promega,
United States; M5122)
GoTaq PCR Master mix (Promega United States; A6001)
GeneRuler 100 bp DNA Ladder, ready-to-use (Thermo
Fisher, United States; SM0243)
DNA Gel Loading Dye (6×) (Thermo Fisher, United States;
R0611)
DNF-474 High Sensitivity NGS Fragment Analysis Kit (1–
6,000 bp) (Advanced Analytical, United States).
Reagent Setup
Before preparing the final solutions, filter both the water and
all the stock solutions. Here volumes are calculated for three
precipitations: one for the protein of interest (NICD) plus
positive (H3) and negative control (IgG). Scale up if more TFs
are planned to be used.
1% FA-PBS (fresh/1 ml for tissue): Mix 972 µl of PBS and
28 µl of FA.
Glycine (2 M stock): Solubilize 1.5 g of glycine in 10 ml
of Milli-Q water.
Lysis buffer (fresh/1 ml): Mix 30µl of SDS [10% (vol/vol) stock
solution], 20 µl of EDTA (0.5 M stock solution), 50 µl of Tris pH
8.0 (1 M stock solution), 10 µl of PIs, and fill with filtered Milli-
Q water to a final volume of 1 ml. Keep on ice until use. Final
concentrations: 0.3% SDS, 10 mM EDTA, 50 mM Tris pH 8.0. !
Critical PI must be added just before use.
IP buffer (10× stock/15 ml): Mix 3 ml of HEPES pH 8.0 (1 M
stock solution), 6 ml of NaCl (5 M stock solution), 600 µl of
EDTA (0.5 M stock solution), and fill with filtered Milli-Q water
to a final volume of 15 ml. Final concentrations: 0.2 M HEPES pH
8.0, 2 M NaCl, 0.02 M EDTA. IP stock solution can be stored in
the fridge for several months.
IP buffer (1× fresh/3 ml): Mix 300 µl of high salt IP buffer
(10× stock), 30 µl of NaDOC [10% (vol/vol) stock solution],
300 µl of Triton X-100 [10% (vol/vol) stock solution], 30 µl
of PIs, and fill with filtered Milli-Q water to a final volume of
3 ml. Keep on ice until use. Final concentrations: 1% high salt
IP buffer, 0.1% NaDOC, 1% Triton X-100 ! Critical PI must be
added just before use.
Washing buffer – reduced SDS (stock/50 ml): Mix 2.5 ml of
HEPES pH 7.6 (1 M stock solution), 1.5 ml of NaCl (5 M stock
solution), 5 ml of Triton X-100 [10% (vol/vol) stock solution],
500 µl of NaDOC [10% (vol/vol) stock solution], 250 µl of
SDS [20% (vol/vol) stock solution], and fill with filtered Milli-
Q water to a final volume of 50 ml. Washing solutions can be
stored in the fridge for several months. Final concentrations:
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50 mM HEPES pH 7.6, 2 mM NaCl, 1% Triton X-100, 0.1%
NaDOC, and 0.1% SDS
Washing buffer – reduced SDS buffer + NaCl (stock/15 ml):
Mix 15 ml of reduced SDS buffer and 600 µl of NaCl (5 M
stock solution). Washing solutions can be stored in the fridge for
several months. Final concentrations: 0.2 M NaCl.
Washing buffer – NP-40 buffer (stock/25 ml): Mix 0.2 ml of
Tris–HCl pH 8.0 (1 M stock solution), 0.625 ml of LiCl (8 M stock
solution), 40 µl of EDTA (0.5 M stock solution), 1 ml of NP-40
[10% (vol/vol) stock solution], 1 ml of NaDOC [10% (vol/vol)
stock solution], and fill with filtered Milli-Q water to a final
volume of 25 ml. Washing solutions can be stored in the fridge
for several months. Final concentrations: 8 mM Tris–HCl pH 8.0,
2 mM LiCl, 0.8 mM EDTA, 0.4% NP-40, and 0.4% NaDOC.
Washing buffer – TE buffer (stock/50 ml): Mix 0.5 ml of
Tris–HCl, pH 8 (1 M stock solution), 100 µl of EDTA (0.5 M
stock solution), and fill with filtered Milli-Q water to a final
volume of 50 ml. Washing solutions can be stored in the fridge
for several months. Final concentrations: 10 mM Tris–HCl,
pH 8, 1 mM EDTA.
Elution buffer (fresh/2 ml): Mix 100 µl of Tris, pH 8 (1 M
stock solution), 40 µl of EDTA (0.5 M stock solution), 100 µl of
SDS [20% (vol/vol) stock solution], and fill with filtered Milli-Q
water to a final volume of 2 ml. Elution buffer can be stored in the
fridge for several months. Final concentrations: 50 mM Tris pH
8, 10 mM EDTA, and 1% SDS.
Protein A- or protein G-sepharose beads (PierceTM Protein
A/G Agarose; Thermo Fisher, United States; 20421).
Primers List
Primers were obtained from Microsynth, Switzerland.
Forward Reverse
Hes5 5′-GGG AAA AGG
CAG CAT ATT GAG
GCG-3′
5′-CAC GCT
AAA TTG CCT
GTG AAT TGG
CG-3′
DLL1 5′-GTC TCA GGA
CCT TCA CAG
TAG-3′
5′-GAG CAA
CCT TCT CCG
TAG TAG-3′
GAPDH 5′-GAT TAC GGG
ATG GGT CTG
AA-3′
5′-GCT GCA
CCT CTG GTA
ACT CC-3′
Immunohistochemistry
Floating coronal brain sections from the TNR-EGFP mice,
exposed to a novel environment (Alberi et al., 2011), were
processed for fluorescent IHC according to the previously
published protocols (Marathe et al., 2017) using Rabbit anti-
NICD (Cell Signaling, United States; #4147) and goat anti-
EGFP (Rockland, United States; #600-102-215). Cy3 donkey
anti-rabbit (Jackson Immunoresearch, United Kingdom; #711-
165-152) and Cy2 donkey anti-goat (Jackson Immunoresearch,
United Kingdom; #705-225-147) were used as secondary
antibodies. DAPI (Sigma–Aldrich, United States; D9542) was
used for nuclear counterstaining.
Western Blot
Input, unbound, and ChIP-NICD fractions were collected
and de-crosslinked by adding 11 µl of 5 M NaCl and
4 µl of RNaseA, and incubating in the thermoshaker for
4 h at 42◦C with gentle shaking. Proteins were extracted
with Trizol (Trifast; Peqgold, Germany) and resuspended
in loading buffer. Twenty-five microliters of protein was
loaded onto a 10% polyacrylamide electrophoretic gel. Western
blot was conducted as previously described (Marathe et al.,
2017) using two primary antibodies: polyclonal goat anti-
Notch1 against the c-terminus, 1:1000 (sc-6014; Santa Cruz
Biotechnology, United States) and mouse anti-β-actin, 1:2000
(sc-81178; Santa Cruz Biotechnology, United States); and
two secondary antibodies diluted 1:2000: Cy3 donkey anti-
goat (Jackson Immunoresearch, United Kingdom; # 705-165-
147) and Cy2 donkey anti-mouse ( Jackson Immunoresearch,
United Kingdom; # 715-225-150). Visualization was performed
through a fluorescent imager (Omega Lum G from Aplegen).
PROCEDURE
ChIP Protocol Overview
The protocol can be essentially divided into several phases.
During the first step, the sample is treated with formaldehyde
to cross-link proteins and DNA within ∼2 Å of each other. As
a result, proteins are covalently bound to their target sequences
on the DNA and provide a snapshot of TF occupancy. Later,
the chromatin fraction is released from the nucleus by the
mean of a lysis buffer, fragmented into small pieces (ranging
from 200 to 500 bp) with a sonicator, and then subjected to
immunoprecipitation with chosen antibodies. Once immune
complexes are obtained, they are separated from the unbound
fraction by using protein A- or protein G-sepharose beads
(magnetic protein A/G beads can be used instead of sepharose
beads, however, washes are performed using an appropriate
magnetic tray). After extensive washing to limit the nonspecific
binding, the immune-bound complexes are eluted, decrosslinked
by proteinase K digestion, and then purified in order to be
analyzed (Figure 1).
Protein–DNA interactions can, then, be approached
fundamentally in two ways: (i) by looking at the presence
of specific sequences in the immunoprecipitated DNA by PCR
amplification or (ii) by combining genome-wide approaches
culminating in a method for deep protein–DNA interactions
analysis: ChIP–Seq.
Considerations Before Starting
• In order to perform a tissue-specific ChIP analysis, it is
important to select the specific part of the tissue you are
interested in. For peripheral organs, blood could interfere
with the purity of your sample, therefore is recommended
to transcardially perfuse the animal with saline solution
before dissection.
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FIGURE 1 | Schematic of the ChIP method and its timing. After tissue processing, DNA and proteins are reversibly crosslinked with short formaldehyde incubation
(15 min) to maintain the association of proteins with their target DNA sequence. In our ChIP experiment, NICD and RBPjK are first crosslinked with DNA and then
cells lysed with ionic lysis buffer (10 min). Chromatin is later fragmented with ultrasounds (30 min) and precleaned with sepharose beads incubation (1 h 40 min).
Once all the unspecific DNA fragments are removed, proteins bound to DNA are ready to be targeted by the selected antibody. After ON incubation,
antibody–protein–DNA complexes are precipitated using beads (3 h). Washes and elution (5 h) lead to target genes that once purified (5 h) are ready for
further applications.
• The tissue could be made of subregions with different
cell populations where the signaling behaves differently.
It is worth to study a priori your tissue anatomy
and composition to reduce the background and obtain
unequivocal results. In our case, during hippocampus
dissection, we carefully removed the dentate gyrus
(composed by neuronal progenitor cells and granule cells)
and then we selected just the CA field (Sultan, 2013). For
the cortex, we removed the white matter to increase the gray
matter content for ChIP analysis.
• While planning the experiment, remember to include
always a positive control as a very abundant core histone
protein (i.e., H3) and a negative control that is a sample
treated in the same way as in the immunoprecipitated
samples but without Ab or with a non-specific Ab (i.e., IgG).
• For optimal chromatin yield and ChIP results, it is
important to use at least 25 mg of tissue for each
immunoprecipitation. The chromatin yield does vary
between tissue types and some tissues may require more
than 25 mg depending on their cell density. Since positive
and negative control must be included, at least 75 mg of
tissue is required.
Stepwise Procedure
Crosslinking (timing: ca. 40 min):
Before starting the procedure, prepare all your solutions and
keep them refrigerated. Switch on the cold centrifuge and set
the Bioruptor sonicator at 4◦C. Perform all steps on ice to avoid
proteins degradation.
1. After tissue dissection from an anesthetized mouse
(Figure 2A), snap-freeze the tissue in liquid nitrogen or, if
fresh tissue is required, proceed with the protocol.
2. Transfer quickly the tissue in a glass dish
already placed in ice.
3. Rapidly put 40 µl of 1% FA-PBS on your tissue piece (this
will fix your tissue while it is thawing), start the timer
(already set on 15 min), and finely mince the fresh/thawed
tissue with two pre-chilled razor blades for 4 min (until it
appears slurry and homogeneous).
4. Add 450 µl of 1% FA-PBS in the dish and transfer the
tissue to a 1.5 ml tube. Use other 450 µl 1% FA-PBS to
harvest tissue residues from the dish and move it into
the tube. Incubate for the remaining 10 min at room
temperature (RT) on the rotating wheel (make sure to
safe-lock the tubes!).
5. Add 63 µl of glycine 2 M to the 940 µl of 1% FA-PBS
(final concentration 0.125 M) to terminate cross-linking.
Incubate for 10 min at RT on the rotating wheel (make sure
to safe-lock the tubes).
6. Wash three times with cold PBS with freshly added PI:
a. Add 500 µl of 1× PBS+PI
b. Invert several times
c. Spin gently at 4◦C for 1 min
d. Remove supernatant
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FIGURE 2 | Expression of NICD in cortex and hippocampus and chromatin shearing of the two brain tissues. (A) Sagittal brain sections, view from the midline,
display the hippocampus and cortex. Example of immunofluorescence for NICD (red) in (B) cortex and (C) hippocampus of the transgenic mouse line (TNR, for
transgenic Notch reporter) expressing enhanced green fluorescent protein (EGFP) in cells with Notch canonical signaling activation. Nuclei are stained in blue. (D) CA
hippocampal fields and cortical tissue 1% formaldehyde fixed are sonicated for 30 cycles (30′′ ON/30′′ OFF) with the Bioruptor R© PLUS at HIGH power setting. All
samples were treated with RNase and Proteinase K prior to gel electrophoresis. Scale bar in B and C is 25 µm.
7. Resuspend the tissue in 600 µl of ice-cold lysis buffer with
freshly added PI (first add 200 µl, start to pestle, then add
the remaining 400 µl).
8. Smash the tissue with a pestle by going 50 times up and
down until the solution is clear and without clumps.
9. Keep the lysate 10 min on ice.
! Safe stop. Samples can be stored at−20◦C at this point.
Chromatin sonication (timing ca. 40 min):
Chromatin needs to be fragmented by sonication into
not too short and not too long fragments in order to
be precipitated.
Extensive sonication could most likely hit TF-
binding sequences and impair them, while long
fragments obtained with short sonication are difficult
to precipitate.
Sonication conditions should be optimized for your
experimental settings (see the section “Anticipated
Results”). Avoid foaming as this results in a decrease of
energy transfer within the solution and will decrease the
sonication efficiency.
10. Transfer the lysate in TPX tubes from Diagenode. Prepare
three tubes with 200 µl each.
11. Bioruptor Plus (Diagenode, Belgium):
Power: High
Runs: 3× 10 cycles
Interval: 30′′ ON/30′′ OFF
Note: Vortex gently and spin down between each run.
During these 30 min, start washing beads.
12. Centrifuge at 13,500 rpm, 4◦C for 10 min.
13. Collect the supernatant and transfer all 600 µl
in one 2 ml tube.
! Safe stop. Samples can be stored at−20◦C at this point.
Determination of DNA fragment size (timing ca. 5 h):
Sonication is the key step for a successful ChIP experiment
and the optimal sonication settings should be determinate
for each experimental tissue. Therefore is a good practice
to check DNA fragments on agarose gel first times
ChIP is performed.
14. Prepare a mix with 60 µl of elution buffer, 4.8 µl of 5 M
NaCl, 2 µl RNase A (10 mg/ml), and 40 µl of chromatin.
Incubate while shaking at 65◦C for 1 h.
15. Add 4 µl proteinase K and incubate 3–4 h at 65◦C [this
incubation could be extended overnight (ON)].
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FIGURE 3 | Profiling of ChIP fragments. (A–D) Electropherograms of automated capillary gel electrophoresis. Size profiles of purified DNA after immunoprecipitations
from cortical and hippocampal CA field lysates (A’–D’) show the fragment length distribution for (A, A’) input, (B, B’) H3, and (C, C’) NICD showing a bimodal
distribution and a major peak around 200 bp. (D, D’) IgG fragment analysis shows a sparse, mostly background peaks. DNA size (bp) is shown.
16. Add 100 µl of phenol/chloroform (1:1), agitate vigorously.
17. Centrifuge for 10 min at 13,500 rpm, 4◦C.
18. Collect the aqueous phase.
19. Add 100 µl chloroform/isoamyl alcohol (1:1).
20. Centrifuge for 10 min at 13,500 rpm, 4◦C.
21. Collect the aqueous phase.
22. Add 2 µL of glycogen (20 mg/mL) and 30 µl of
NaCH3COOH (3 M).
23. Flick the tube and add 100 µl of isopropanol.
24. Agitate vigorously the tube several times for 1 min.
25. Leave on ice for 10 min or keep in the freezer
for 5 min.
26. Centrifuge 20 min at 13,500 rpm, 4◦C.
27. Decant supernatant.
28. Wash by adding 500 µl of 75% EtOH. Spin 5 min at
13,500 rpm, 4◦C, and decant the supernatant.
29. Air dry and resuspend in 20 µl of ddH2O. Incubate several
minutes while shaking at 42◦C to dissolve DNA.
30. Run purified DNA in a 1.5% agarose gel with a 100 bp DNA
marker to determine fragment size.
Beads washing (timing ca. 15 min):
31. Take the IP buffer 10× from the fridge and make 3 ml of IP
buffer 1× and add 20 µl of PI.
32. Transfer 20 µl of beads for preclearing and 40 µl for
the IPs. Cut the tip used in order to dispense them. You
will have in total two 1.5 ml tubes for preclearing and
three for IPs.
33. Wash beads three times with 500 µl PBS: At each step spin
down the beads shortly with gentle centrifugation so they
don’t break, wait until they settle down, and then aspirated
gently the PBS with a pump using a 10 µl tip and going
progressively down with the tip.
34. Wash one time with 500 µl IP buffer with PI. Keep
preclearing beads on ice and store IP beads still in IP
buffer in the fridge.
Pre-clearing (timing ca. 1 h 40 min):
Pre-clearing is an optional step but is recommended to
reduce non-specific binding to the beads.
SDS presence in the lysis buffer is important since it
enhances lysis and sonication but it also interferes with
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FIGURE 4 | ChIP validation. (A) Representative western blot of Notch1 protein present in the input, enriched in the ChIP-NICD sample and absent in the unbound
solute. β-Actin is used to detect the housekeeping protein in the input and unbound fractions. (B, B’) PCR analysis of hippocampus ChIPed with antibodies specific
for RBPjK and NICD show an amplicon band for the promoter region of the canonical Notch target, Hes5 (B), but no band for the promoter region of DLL1 (B’),
chosen as a negative control. Inputs and whole DNA are shown as a positive reference and water controls for contaminants. (C) Results from real-time qPCR of
ChIPed tissue with the NICD antibody shows a fourfold and twofold enrichment of the specific Notch target, Hes5, compared to the GAPDH promoter region in the
hippocampus and cortex, respectively. The ChIPed samples with the antibody against acetyl-histone H3 antibodies show the expected amplification of the Hes5 and
the GAPDH promoter in both tissues and there is no amplification in the ChIPed samples with IgG.
protein/antibody and antibody/beads binding. Therefore, it
has to be diluted up to 0.1%.
35. Add IP buffer to the chromatin in 3:1 proportion (600 µl
chromatin+ 1200 µl IP buffer)
36. Split the chromatin over the two pre-clearing tubes and add
to the 20 µl beads you kept on ice (900 µl each).
37. Incubate for 1–1.5 h @ 4◦C on the rotating wheel (make
sure to safe-lock the tubes).
38. Spin down the beads from the pre-cleared chromatin,
collect the supernatant, and discard the 20 µl beads.
39. Measure the DNA concentration using Qubit.
40. Take 5% of the total volume of pre-cleared chromatin as
input material and freeze it.
! Safe stop. Samples can be stored at−20◦C at this point.
Immunoprecipitation and washes (timing ca. 16 h):
The optimal antibody concentration should be calibrated
for each antibody as this can improve the signal-
to-noise ratio of your experiment (see the section
“Anticipated Results”).
41. Divide the chromatin into three tubes (600 µl per tube)
and add the antibodies to each pre-cleared chromatin: (1)
specific for the TF, NICD; (2) negative control, IgG; and (3)
positive control, histone H3.
42. Put the chromatin with antibodies on a rotating wheel to
mix ON at 4◦C (make sure to safe-lock the tubes!).
43. Transfer the chromatin+ antibodies to the Eppendorf with
the 40 µl beads you kept on ice/on the fridge.
44. Rotate for 3 h at 4◦C on the rotating wheel (make sure to
safe-lock the tubes).
45. Spin down the beads and discard the supernatant.
46. Wash three times with the reduced SDS buffer: At each
step, spin down the beads shortly with gentle centrifugation
so they don’t break, wait until they settle down and then
aspirate the buffer with the sucker using a 10 µl tip and
going progressively down with the tip.
47. Wash one time with reduced SDS+ NaCl buffer.
48. Wash one time with NP-40 buffer.
49. Wash one time with TE buffer.
Eluting the chromatin (timing ca. 15 min):
Prepare fresh elution buffer.
50. Add 500 µl of elution buffer to the beads and 470 µl
to the 5% input.
51. Incubate for 12 min at 65◦C while shaking. Flick the
tube vigorously once during this incubation and once the
incubation is finished.
52. Centrifuge 13,500 rpm, 4◦C for 1 min.
53. Transfer the supernatant to a new tube, discard the beads.
Reversing the crosslinking (Input and IP-ed Chromatin)
(timing ca.4-5 h):
54. Add 11 µl of 5 M NaCl. Flick tubes briefly.
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55. Add 4 µl of RNaseA to the eluted chromatin and
incubate in the thermoshaker for 1 h at 65◦C with
gentle shaking.
56. Add 4 µl of proteinase K to the eluted chromatin and
incubate in the thermoshaker for 3–4 h at 65◦C with gentle
shaking (this incubation could be extended ON).
Extraction and purification (timing ca. 1.5 h):
Be careful during the whole extraction and work under
a chemical hood.
57. Add 500 µl of phenol/chloroform (1:1), agitate
vigorously.
58. Centrifuge for 10 min at 13,500 rpm, 4◦C.
59. Collect the aqueous phase.
60. Add 500 µl chloroform/isoamyl alcohol (1:1),
agitate vigorously.
61. Centrifuge for 10 min at 13,500 rpm, 4◦C.
62. Collect the aqueous phase.
63. Add 50 µl of NaCH3COOH (3 M).
64. Flick the tube and add 500 µl of isopropanol.
65. Agitate vigorously for 1 min.
66. Keep samples on ice for 10 min or put the samples at
−20◦C for 5 min.
67. Centrifuge for 20 min at 13,500 rpm, 4◦C.
68. Decant the supernatant.
69. Wash by adding 500 µl of 75% EtOH. Spin 5 min at
13,500 rpm, 4◦C, and decant the supernatant.
70. Air dry under the hood and resuspend in 10 µl of
ddH2O. Incubate several minutes while shaking at 42◦C
to dissolve DNA.
71. Measure your DNA concentration using Qubit.
PCR
Primer should be designed bearing in mind that the sequence you
precipitated is small and must include the TF-binding sequence.
Make sure it is included in your primer design (see the section
“Anticipated Results”) (Figure 4B).
72. Prepare your (Master mix) × n samples, using for
each sample:
– 7.5 µl hot start GoTaq
– 0.5 µl primers (10 µM)
– ddH2O up to 15 µl
73. Add at least 1 ng of DNA
74. Use the following ChIP program:
step ◦C H:mm:ss Go to
1 94.0 0:02:00
2 94.0 0:00:30
3 56.5 0:00:30
4 72.0 0:00:30 29×→ Step 2
5 72.0 0:10:00
6 4.0 inf
75. Run PCR products in 1.3% agarose gel.
qPCR
Once a specific amplicon is identified by qualitative PCR, the
relative efficiency of chromatin pull down should be evaluated via
qPCR (Figure 4C).
The primers used for qPCR are the same as for the PCR.
76. Prepare your (Master mix) × n samples, using for
each sample:
– 7.5 µl Promega GoTaq qPCR master mix
– 0.5 µl Primers (10 µM)
– ddH2O up to 15 µl
77. Add 1 ng of DNA.
78. Run the standard amplification program according to the
manufacturer instructions.
ANTICIPATED RESULTS
Starting Material Amount and
Crosslinking
Before starting, it is always recommended to check the specificity
of the antibody and the activity rate of your TF in the tissue
of your interest. One possible way to do this is to perform an
IHC of your region of interest. This would help establish the
range of starting material to use since this is going to influence
the entire experiment. For the experiment we performed in
this paper, we found a sparse and nuclear pattern of NICD in
cortical tissue as well as in the CA fields of the hippocampus
(Figures 2B,C). For low concentrations of the TF, as in our case,
more chromatin should be used during immunoprecipitation.
It is recommended to increase the amount of chromatin rather
than the amount of antibody since the latter is going to increase
the background. To further confirm the right amount of starting
material, it is important to assess the chromatin yield after cell
lysis. Each tissue has a different chromatin yield that depends
on cell density and tissue composition. Therefore, it is important
to measure the DNA concentration with a fluorometric method
(Qubit) to evaluate how much tissue and/or lysis buffer is
required for the next steps.
Our sample preparation section is well optimized for fresh-
frozen samples. In clinical analyses, the vast majority of samples
need to be stored at −80◦C for later analysis or dispatching
to other labs. One of the improvements provided by this
protocol is the ongoing fixation while the tissue thaws. This
captures chromatin–protein architectural organization in the
moment of defrosting and prevents loss of biological content
due to cell damage, thus, preserving the integrity of the sample.
Furthermore, the mincing step with the razor blades makes
fixative penetration uniform and easier and is superior to
mechanical treatment that causes cell loss. That said, cross-
linking efficiency is empirical and should be tested by modifying
either incubation time or formaldehyde concentration prior to
performing the whole procedures. Remember that extensive
cross-linking may decrease the solubility of any target DNA–
protein complex and cause it to be entrapped in the insoluble
material removed by sedimentation.
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Chromatin Shearing
Sonication is very sensitive to changes, and its efficiency depends
on several factors such as temperature, cell type, and density,
volume, SDS concentration, and the extent of cross-linking. For
reproducible results, these parameters should be kept constant.
We use the Bioruptor Plus sonicator from Diagenode
equipped with a cooling water bath and a tray holding up to six
samples. To shear DNA, ultrasonic waves are transferred through
water generating heat. With this system, the temperature is kept
at 4◦C preserving sample antigenicity. This system is suitable
for shearing up to six sample at a time, assuring reproducibility
between replicates. Samples’ volume, tissue composition, and
density impact the sonication outcome. If new tissues are going to
be tested with this protocol and there is no previous knowledge of
their sonication settings, several optimization steps are required.
Samples volumes should be fixed at the beginning and sonication
efficiency calibrated by testing several aliquots of the starting
material at increasing dilutions in lysis buffer (es. 1×, 2×, 4×, 6×,
8×, 10×). By keeping settings constants, it is possible to retrieve
the optimal conditions for your tissue.
We achieved a nice shearing (Figure 2D) using 200 µl of
both cortical and hippocampal lysates (0.3% of SDS) with a DNA
concentration between 6 and 7 ng/µl performing three runs of 10
cycles each with intervals of 30 s ON and 30 s OFF at high power.
It is important to notice that very low SDS concentration
and prolonged crosslinking also impact the shearing efficiency.
This should be taken into account if any changes are
planned to be made.
Shearing was also tested after ChIP by the mean of Fragment
Analyzer. We found some inconsistencies between agarose
gel and Fragment Analyzer analysis. In both cortex and
hippocampus, it is possible to notice a bimodal distribution
in the input as well as in immunoprecipitates (Figure 3).
This may be due to the higher sensitivity of capillary gel
electrophoresis to residual contaminants (ions, SDS, proteins,
etc.), due to overloading or to conformation/spatial structure of
DNA molecules. However, the low peak is predominant in all
sample, and the majority of DNA fragments ranging between
200 and 500 bp (Figures 3A,B,D). It is also possible to notice
that H3 and NICD antibodies show the same behavior in the
two tissues (Figures 3B,B’,D,D’) whereas the mock precipitated
IgG sample (the negative control) has barely precipitate
fragments (Figures 3C,C’).
PCR Results Analysis
To validate the enrichment of NICD in the ChIP-NICD complex
compared to the input and unbound fractions, we performed
western blot analysis for Notch1 (c-terminus) and used β-actin as
TABLE 2 | Troubleshooting table.
Problem Possible reason Solution
Fragmented chromatin concentration is
too low
1. Incomplete tissue lysis.
2. Not enough tissue used for the chromatin preparation.
1. Check for single-cell suspension using a microscope.
2. If incomplete tissue lysis is excluded, try increasing the
starting material amount.
Fragments are too large when
visualized in Agarose gel.
1. Samples may have been over-crosslinked.
2. Too much input material was processed.
3. Insufficient sonication.
1. Reduce the crosslinking time.
2. Reduce the amount of tissues per sonication or dilute it
more in Lysis buffer.
3. Conduct a sonication time course.
Fragments are too short when
visualized in Agarose gel.
Samples may have been subjected to excessive shearing
by sonication and/or conditions are too harsh.
Conduct a sonication time course. Do not increase the
duration of sonication steps, as this could overheat the
sample and lead to loss of epitopes.
DNA pellets do not solubilize after
extraction.
DNA pellet is overdried. Heat the pellet at 37◦C until it is completely solubilized. Try
to avoid excessive drying of the DNA pellet.
No product or a very little band for the
input after PCR reactions.
1. DNA added to the PCR reaction was not enough. 2.
Conditions are not optimal.
1. Add more DNA to the PCR reaction or increase the
number of amplification cycles.
2. Optimize the PCR conditions for experimental primer set
using purified DNA from cross-linked and fragmented
chromatin.
No product in the positive control after
PCR reactions.
1. Not enough chromatin or antibody added to the IP
reaction.
2. DNA could have been lost during washes.
3. Incomplete elution of chromatin from beads.
1. Try to add more chromatin or more antibody.
2. Prepare new wash solutions.
3. Try increasing elution time and shake tubes more
frequently.
Visible product in the negative control. 1. Insufficient washes.
2. Too much chromatin added to the IP reaction.
1. Increase the number and/or stringency of the washes after
immunoprecipitation.
2. Reduce the amount of negative control antibody or the
amount of chromatin.
No band for the IP product after PCR
reaction.
1. Not enough antibody added to the IP reaction.
2. Not enough DNA added to the PCR reaction.
3. Not enough chromatin added to the IP reaction.
1. Typically a range of 1–5 µg of antibody is added to the IP
reaction; however, the exact amount depends greatly on
the individual antibody. Try to use ChIP-grade antibodies.
2. Increase the number of amplification cycles or add more
DNA to the PCR reaction.
3. Try to add more chromatin or increase the amount of
starting tissue.
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negative control. The ChIP-NICD fraction is enriched in cleaved
Notch1 1.6-fold compared to the input. Precipitation is specific
to NICD as indicated by the absence of β-actin, which is instead
present in the input and unbound fraction (Figure 4A).
Downstream assays to investigate protein–DNA interaction
at genomic binding sites are polymerase chain reaction
(PCR), quantitative polymerase chain reaction (qPCR), DNA
microarray (ChIP-on-chip), and massively parallel DNA
sequencing (ChIP-seq).
Normal PCR is the easiest but less reliable approach to analyze
a ChIP experiment product. It is a fast and cheap method to
assess the quality/purity of the immunoprecipitated chromatin,
but it is less employed for detection of potential target genes
because it is not quantitative. In that case, it is preferable to
use qPCR instead since it provides an accurate determination of
levels of specific DNA in ChIP-ed samples. In both cases, primers
should be designed for a region the TF binds to, the positive
control, and for a region, your TF is supposed not to bind,
representing the negative control. If there is previous knowledge,
it is recommended to first identify the binding site sequence
in silico in order to accurately amplify the extracted DNA.
If there are no known sites but candidate target genes are
available, it is possible to design primers along the length of
potential regulatory regions such as promoters and conserved
noncoding sequences within intergenic regions. If candidate
target genes or potential sites are not available, ChIP-chip (Buck
and Lieb, 2004) or ChIP-seq (Fanelli et al., 2011; Furey, 2012)
should be considered instead.
In our case, we know that RBPjK-binding motif is
CGTGGGAA (Tun et al., 1994). Therefore, we designed a set
of primers looking at the presence of these eight nucleotides
strings within the sequence of the Hes5 promoter, a canonical
Notch signaling target gene. We also chose Delta-like protein 1
(DLL1) promoter as a negative control region since there are no
RBPjK-binding motifs. A good example of purity was achieved as
demonstrated by the PCR and qPCR results (Figure 4). For Hes5
PCR results, we observe amplification in both RBPjK and NICD
samples while there is no amplification in IgG lane suggesting
that non-specific binding is absent (Figure 4B).
On the other hand, the DLL1 PCR shows no amplification
(Figure 4B’), indicating the specificity of the ChIP for RBPjK
and NICD targets.
Quantitative polymerase chain reaction analysis further
confirms the specificity obtained using Hes5 as a positive
control and GADPH as a negative control (Figure 4C). Binding
efficiency is expressed by the percent input method that includes
normalization for both background levels and input chromatin
(Lacazette, 2016).
This protocol is suitable for sequencing (data not shown).
From the ChIPed fragments, a library is prepared according
to manufacturer’s instruction and loaded into the flow-cell for
sequencing; trimmed sequence reads are mapped to a reference
genome. Next, peaks are found using peak-calling algorithms
(Nakato and Shirahige, 2017). To further analyze the data,
differential binding or motif analyses are common endpoints
of ChIP-seq workflows. The ChIP-Seq procedure allows to
map TF-target sequences and provide a functional readout of
gene activation in complex tissues, such as the brain, and
under different experimental conditions: i.e., environmental
enrichment, aging, neurodegeneration, neuroinflammation, etc.
Understanding the downstream targets of signaling pathways
critical for plasticity and neurodegeneration will facilitate the
discrimination of beneficial versus detrimental genes’ products
that can be employed for developing therapeutic strategies
targeting brain diseases.
Concluding, there are already other protocols describing ChIP
procedures (Table 1; Braveman et al., 2004; Nelson et al., 2006;
Dahl and Collas, 2008; Sailaja et al., 2012; Schmidl et al., 2015).
However, all these methods are either centered on abundant
histone modification or use cells suspensions as starting material.
The added value of this protocol is the possibility to perform all
the downstream analyses described (i) from a tissue subregion,
(ii) precipitating for a rare transcriptional activator (NICD),
and (iii) yielding a sufficient amount of DNA with reduced
background. The advantage of performing ChIP for NICD,
compared to RBPJK, has undisputed advantages as only activated
loci under specific conditions will be captured within the tissue
revealing active transcriptional targets.
Troubleshooting
Table 2 indicates issues which can occur during the procedure
with a possible reason and suggestions to solve and avoid them.
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